Residual Inflammation Can Linger in Psoriasis Patients Despite Skin Treatment

Should you be tested for inflammation?

Let’s face it: inflammation has a bad reputation. Much of it is well-deserved. After all, long-term inflammation contributes to chronic illnesses and deaths. If you just relied on headlines for health information, you might think that stamping ...

Residual inflammation can linger in psoriasis patients despite skin treatment

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease.

Study links residual inflammation in psoriasis patients to obesity and fatty liver disease

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease.

Study Links Residual Inflammation in Psoriasis Patients to Obesity and Fatty Liver Disease

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease. The findings of the study�opens in new tab/window in the Journal of Investigative Dermatology �opens in new tab/window (JID), published by Elsevier, could lead to more targeted and effective treatments that …

Residual Inflammation in Psoriasis Linked to Health Problems

People with psoriasis who have residual inflammation despite being treated for their condition are more likely to be obese or have other health problems such as cardiovascular or fatty liver disease. Lead investigator Álvaro González-Cantero, MD, PhD, Hospital Universitario Ramón y Cajal, Madrid, and colleagues report in the Journal of Investigative Dermatology that 36% of psoriasis patients in their study had significant residual inflammation, …

Oruka Therapeutics Reveals Next-Gen Psoriasis Treatment Progress at Major Healthcare Conference

Learn about Oruka's innovative biologics pipeline for chronic skin diseases. Key updates on psoriasis treatment development to be shared. Watch live or replay available.